Age

Median (IQR)

Range

56 (50 - 66)

27 - 80

ECOG

0

1

2

1 (1.2%)

73 (84.9%)

12 (14.0%)

Gender

Male

female

75 (87.2%)

11 (12.8%)

Site

Larynx

Hypopharynx

77 (89.5%)

9 (10.5%)

Grade

1

2

3

14 (16.3%)

61 (70.9%)

11 (12.8%)

Tumor T-stage

1

2

3

4

11 (12.8%)

26 (30.2%)

33 (38.4%)

16 (18.6%)

Nodal N-stage

0

1

2

3

51 (59.3%)

5 (5.8%)

26 (30.2%)

4 (4.7%)

AJCC stage

1

2

3

4

11 (12.8%)

16 (18.6%)

17 (19.8%)

42 (48.8%)

Pretreatment hemoglobin (g/dl)

Median (IQR)

<13 (male)

>13 (male)

<12 (female)

>12 (female)

13.1 (11.9 - 14.2)

31 (41.3%)

44 (58.7%)

4 (36.4%)

7 (63.6%)

Median follow-up duration

9.33 (4.2 - 17.7)